||Verinovum Announces Partnership with CentraForce Health via Webinar
||... from Verinovum about how to rearrange the puzzle pieces to better support the patient. For more information or to register for the webinar, please click here . About Verinovum Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, partners organizations to improve operating performance and quality with actionable data. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the ...
||Verinovum Launches Targeted Use Case Data Curation and Enrichment Modules for Chronic and Preventive Care ... ( TULSA O...)
||... and enrichment company Verinovum today announced the launch of its new Data Curation as a Service (DCaaS) solution for payers, providers, healthcare systems, and OEM partners.? Verinovum’s targeted use case modules focus on specific clinical data curation parameters and are custom tailored to provide clients a clear, trusted, comprehensive data curation and enrichment engine required to optimize use case analytics and outcomes. Targeted use cases include chronic care management of ...
||Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry [Research Articles]
||... describe the clinical, pathologic, and genomic features, as well as survival and duration on standard therapies, in patients with AKT1 E17K -mutant versus AKT1 –wild-type ER + metastatic breast cancer. A consistent approach to clinical data curation was harmonized across treatment sites and was operationalized using a common Research Electronic Data Capture (REDCap) database. Results Patient and Disease Characteristics A total of 455 patients with ER + metastatic breast cancer were ...
||Integrating genomic features for non-invasive early lung cancer detection
||... M.F.B., J.B.S., S.S.G., V.S.N., D.A.H., L.V.S. and M.D. A.N.L. performed radiologic analyses. R.F.B., C.H.Y., R.B.K., E.L.C., D.J.M., P.P.M., H.Z.R., A.S.M., C.L.C., R.B., G.J.B., K.C.J., R.B.W., C.A.K. and V.S.N. organised patient enrolment, sample collection and clinical data curation . All authors reviewed the manuscript. Corresponding authors Ethics declarations Competing interests D.M.K. reports paid consultancy from Roche Molecular Diagnostics. A.A.C. reports speaker honoraria and travel support from Roche Sequencing Solutions, Varian Medical Systems ...
||Genome-wide cell-free DNA fragmentation in patients with cancer
||... performed experiments. S.Ø.J., V. Anagnostou, P.F., J.N., K.M., J.B., B.D.W., H.H., K.L.v.R., M.-B.W.Ø., A.H.M., C.J.H.v.d.V., M.V., A.C., C.J.A.P., G.R.V., N.C.T.v.G., M.K., R.J.A.F., J.S.J., H.J.N., G.A.M. and C.L.A. organized patient enrolment, sample collection, and clinical data curation . S.C., A.L., J.P., J.F., V. Adleff, D.C.B., J.E.M., J.R.W., N.N., G.A.M., C.L.A., R.B.S. and V.E.V. analysed and interpreted data. S.C., A.L., J.P., J.F., R.B.S. and V.E.V. wrote the manuscript and incorporated feedback from ...